Cargando…
Case Report: TEMPI syndrome: Report of three cases and treatment follow-up
The TEMPI syndrome is a novel and rare disease with five distinct clinical features: Telangiectasis, Erythrocytosis, Monoclonal gammopathy, Perinephric fluids collection, and Intrapulmonary shunting. Here, we report three cases of TEMPI syndrome and their treatment response. The three patients were...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382296/ https://www.ncbi.nlm.nih.gov/pubmed/35992844 http://dx.doi.org/10.3389/fonc.2022.949647 |
_version_ | 1784769257631907840 |
---|---|
author | Xu, Zhuo-Fan Ruan, Jing Chang, Long Wu, Sijin Lin, Jinkai Wang, Wei Cao, XinXin Zhang, Lu Li, Jian Zhou, Daobin Zhang, Wei |
author_facet | Xu, Zhuo-Fan Ruan, Jing Chang, Long Wu, Sijin Lin, Jinkai Wang, Wei Cao, XinXin Zhang, Lu Li, Jian Zhou, Daobin Zhang, Wei |
author_sort | Xu, Zhuo-Fan |
collection | PubMed |
description | The TEMPI syndrome is a novel and rare disease with five distinct clinical features: Telangiectasis, Erythrocytosis, Monoclonal gammopathy, Perinephric fluids collection, and Intrapulmonary shunting. Here, we report three cases of TEMPI syndrome and their treatment response. The three patients were presented to our department with polycythemia, abdominal distension, and dyspnea. On admission, all patients manifested telangiectasis, erythrocytosis, monoclonal gammopathy, and intrapulmonary shunting. Patient 1 and 2 manifested perinephric fluids collection. In addition, all patients had skin pigmentation, patient 1 and 2 had polyserosal effusion, two symptoms that had not been associated with TEMPI syndrome before. The three patients showed various response to plasma cell-directed therapy. We demonstrated their treatment response by measuring erythropoietin, hemoglobin, and M protein levels throughout therapy. This report suggested that TEMPI syndrome is a rare yet treatable disease. The diagnosis and treatment of it remain challenging. |
format | Online Article Text |
id | pubmed-9382296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93822962022-08-18 Case Report: TEMPI syndrome: Report of three cases and treatment follow-up Xu, Zhuo-Fan Ruan, Jing Chang, Long Wu, Sijin Lin, Jinkai Wang, Wei Cao, XinXin Zhang, Lu Li, Jian Zhou, Daobin Zhang, Wei Front Oncol Oncology The TEMPI syndrome is a novel and rare disease with five distinct clinical features: Telangiectasis, Erythrocytosis, Monoclonal gammopathy, Perinephric fluids collection, and Intrapulmonary shunting. Here, we report three cases of TEMPI syndrome and their treatment response. The three patients were presented to our department with polycythemia, abdominal distension, and dyspnea. On admission, all patients manifested telangiectasis, erythrocytosis, monoclonal gammopathy, and intrapulmonary shunting. Patient 1 and 2 manifested perinephric fluids collection. In addition, all patients had skin pigmentation, patient 1 and 2 had polyserosal effusion, two symptoms that had not been associated with TEMPI syndrome before. The three patients showed various response to plasma cell-directed therapy. We demonstrated their treatment response by measuring erythropoietin, hemoglobin, and M protein levels throughout therapy. This report suggested that TEMPI syndrome is a rare yet treatable disease. The diagnosis and treatment of it remain challenging. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9382296/ /pubmed/35992844 http://dx.doi.org/10.3389/fonc.2022.949647 Text en Copyright © 2022 Xu, Ruan, Chang, Wu, Lin, Wang, Cao, Zhang, Li, Zhou and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Xu, Zhuo-Fan Ruan, Jing Chang, Long Wu, Sijin Lin, Jinkai Wang, Wei Cao, XinXin Zhang, Lu Li, Jian Zhou, Daobin Zhang, Wei Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title | Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title_full | Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title_fullStr | Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title_full_unstemmed | Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title_short | Case Report: TEMPI syndrome: Report of three cases and treatment follow-up |
title_sort | case report: tempi syndrome: report of three cases and treatment follow-up |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382296/ https://www.ncbi.nlm.nih.gov/pubmed/35992844 http://dx.doi.org/10.3389/fonc.2022.949647 |
work_keys_str_mv | AT xuzhuofan casereporttempisyndromereportofthreecasesandtreatmentfollowup AT ruanjing casereporttempisyndromereportofthreecasesandtreatmentfollowup AT changlong casereporttempisyndromereportofthreecasesandtreatmentfollowup AT wusijin casereporttempisyndromereportofthreecasesandtreatmentfollowup AT linjinkai casereporttempisyndromereportofthreecasesandtreatmentfollowup AT wangwei casereporttempisyndromereportofthreecasesandtreatmentfollowup AT caoxinxin casereporttempisyndromereportofthreecasesandtreatmentfollowup AT zhanglu casereporttempisyndromereportofthreecasesandtreatmentfollowup AT lijian casereporttempisyndromereportofthreecasesandtreatmentfollowup AT zhoudaobin casereporttempisyndromereportofthreecasesandtreatmentfollowup AT zhangwei casereporttempisyndromereportofthreecasesandtreatmentfollowup |